DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies (TORCH-Plus)
TranslatiOnal Registry for CardiomyopatHies (TORCH) - Plus as Part of the German Centre for Cardiovascular Research (DZHK)
Sponsor: Charite University, Berlin, Germany
This observational or N/A phase trial investigates Amyloidosis and Arrhythmogenic Right Ventricular Cardiomyopathy and is currently actively recruiting participants. Charite University, Berlin, Germany leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Mar 2023 — Dec 2023 [monthly]
Recruiting
-
Nov 2022 — Mar 2023 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jun 2022 — Nov 2022 [monthly]
Recruiting
-
Apr 2022 — Jun 2022 [monthly]
Recruiting
-
Jan 2021 — Apr 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Charite University, Berlin, Germany
- Deutsches Herzzentrum Muenchen
- German Heart Center
- Goethe University
- Kerckhoff Klinik
- Medical University of Hannover
- Technical University of Munich
- University Hospital Heidelberg
- University Hospital Munich
- University Hospital Schleswig-Holstein
- University Medical Center Goettingen
- University Medical Center Mainz
- University Medicine Greifswald
- University of Mannheim
- Universitätsklinikum Hamburg-Eppendorf
For direct contact, visit the study record on ClinicalTrials.gov .